OTC · Health care

Ctt Pharmaceutical Holdings, Inc. (CTTH)

It posted a net loss of $1.7M. At September 30, 2015 it held $32.1K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 17, 2026.

Watch CTTH in 60 seconds

Price

$0.05

0.00% on the day · September 25, 2026

52-week range $0.04 to $0.10

Market cap

$3.2M

What Ctt Pharmaceutical Holdings, Inc. does

Ctt Pharmaceutical Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker CTTH.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2014	n/a	-$672.2K	-$672.2K	-$0.04	n/a
2013	n/a	-$18.9K	-$18.9K	$0.01	n/a
2012	n/a	-$1.2M	-$1M	-$0.11	n/a
2011	n/a	-$757.9K	$3.7M	$0.40	n/a
2011	n/a	-$2.1M	-$1.1M	-$0.13	n/a

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Ctt Pharmaceutical Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 23, 2026
Material agreement 8-K
September 17, 2026
Quarterly report 10-Q · period to June 30, 2026
August 12, 2026
Other event 8-K
July 24, 2026
IPO registration (amended) S-1/A
July 13, 2026
IPO registration (amended) S-1/A
June 29, 2026
IPO registration (amended) S-1/A
June 16, 2026
IPO registration (amended) S-1/A
May 29, 2026
IPO registration (amended) S-1/A
April 15, 2026
IPO registration (amended) S-1/A
December 30, 2025
IPO registration S-1

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 22, 2026. Insider transactions on SEC

Insider trades

What the people running Ctt Pharmaceutical Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $3.3K worth of shares on the open market in the last 90 days and sold none.

Bought (open market)

$3.3K

last 90 days

Sold

last 90 days

Net bought

66,200

$3.3K

Date	Insider	What	Shares	Price	Value	Filing
September 22, 2026	Ctt Pharmaceutical Holdings, Inc.CEO, Director	Bought	10,100	$0.05	$454.5	Form 4
September 16, 2026	Ctt Pharmaceutical Holdings, Inc.CEO, Director	Bought	10,900	$0.05	$523.2	Form 4
September 10, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	3,500	$0.05	$175	Form 4
September 4, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	9,800	$0.05	$479.2	Form 4
September 2, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	3,000	$0.05	$146.7	Form 4
August 31, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	3,500	$0.05	$171.5	Form 4
August 24, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	2,100	$0.06	$115.5	Form 4
August 20, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	11,500	$0.05	$517.5	Form 4
August 19, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	10,000	$0.06	$590	Form 4
August 14, 2026	Ctt Pharmaceutical Holdings, Inc.CEO	Bought	1,800	$0.06	$111.6	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CTTH

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 1,056,800 shares in total, about $57.1K at the last price.

Holder	Shares	As of
Ctt Pharmaceutical Holdings, Inc.CEO, Director	1,056,800	September 22, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CTTH

What does Ctt Pharmaceutical Holdings, Inc. do?

Ctt Pharmaceutical Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker CTTH.

Is Ctt Pharmaceutical Holdings, Inc. profitable?

No. Over the twelve months to September 30, 2015 it reported a net loss of $1.7M.

When did Ctt Pharmaceutical Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on September 17, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 23, 2026.

Similar companies

TAK

Takeda Pharmaceutical Co Ltd

Compare CTTH with

Compare CTTH with any company

Follow CTTH

Get an email when Ctt Pharmaceutical Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CTTH: get an email when it files

Where the numbers come from

Financial figures are the values Ctt Pharmaceutical Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.